Latest
Senate Judiciary Committee to address rising credit card “swipe” fees
“Once lawmakers hear the facts, Congress needs to quickly pass this landmark pro-consumer legislation," MPC's Kantor argues.
Aetna Better Health of Illinois introduces same-day pharmacy delivery to members
First Medicaid managed care organization in Illinois to offer this service.
CVS Media Exchange launches programmatic in-store audio
As part of the collaboration, Vibenomics will aggregate audio inventory into the programmatic advertising space.
Camber rolls out generic Xeloda
Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers.
New research from Inmar reveals why most marketers can’t measure influencer ROI
86% of marketers invest in Influencers, but few are able tomeasure ROI—Inmar Intelligence reveals how retail media networks can bridge the gap.
Cardinal Health announces two strategic additions to its portfolio
Acquisition of a majority stake in GI Alliance as well as Advanced Diabetes Supply Group.
Wakefern names Sapp VP of Pharmacy and Wellness
Sapp, who brings nearly 20 years of retail pharmacy leadership experience to his new role, will provide guidance to Wakefern members that operate ShopRite Pharmacies in the ever-evolving pharmacy landscape.
NBC/NRF Retail Monitor shows strong retail sales gains in October
“Healthy spending resumed in October as consumers continued to benefit from this year’s job gains and higher wages,” NRF president and CEO Matthew Shay said.
Just for Teens teams with Wegmans to offer skin care products to teen shoppers
The Just for Teens Facial Wash and Moisturizer are carefully formulated for preteens and teens with sensitive, oily, and acne-prone skin.
Retailers brace for supply chain disruptions amid potential port strikes and tariff hikes
“Neither of these developments is good for retailers, their customers, or the broader economy.”
GlobalData: Trump’s return sparks uncertainty for U.S. pharma and health care industries
Trump's return to the White House brings renewed uncertainty to the U.S. pharmaceutical and health care industries, with potential shifts in policies affecting millions.
